On ECHEMI
Home > Drugs > Nifedipine sustained-release tablets (I)

Nifedipine sustained-release tablets (I)

Function and Efficacy

Not yet clear.

Ingredients

The main ingredient of this product is: nifedipine.

Name Description Content CAS NO. Manufacturer
NifedipineIngredients

Not yet clear

More
21829-25-4 74

Appearance

This product is a film-coated tablet, which appears yellow after removing the film coating.

Indication

Angina pectoris: especially variant angina pectoris.

Usage and Dosage

1. Swallow the whole tablet on an empty stomach. Do not chew or break it apart before taking. 2. Start with a small dose. The initial dose is 20 mg/time, and the maximum dose is 60 mg/time, once a day. The maximum daily dose does not exceed 120 mg. 3. The dose of nifedipine should be gradually adjusted depending on the patient's tolerance and control of angina pectoris. The patient's blood pressure needs to be monitored before increasing the dose. If the patient's symptoms are obvious, the dose adjustment period can be shortened according to the patient's response to the drug. 4. No rebound symptoms were observed when the drug was discontinued, but the dose still needs to be gradually reduced, and the patient's condition should be closely observed. 5. The dose of ordinary preparations can be safely replaced with the dose of sustained-release preparations. For example: ordinary preparations 30 mg/time, three times a day, can be replaced with sustained-release preparations 90 mg/time, once a day.

Adverse Reactions

1. Liver: Occasionally, jaundice and elevated glutamate oxaloacetate aminotransferase and glutamate pyruvate aminotransferase may occur. 2. Circulatory system: Occasionally, chest pain, headache, flushing, dizziness, palpitations, decreased blood pressure, lower limb edema may occur. 3. Allergies: Occasionally, allergic symptoms such as measles and itching may occur. 4. Digestive system: Occasionally, abdominal pain, nausea, loss of appetite, constipation may occur. 5. Oral cavity: Gum hypertrophy may occur. 6. Metabolic abnormalities: Occasionally, symptoms of hyperglycemia may occur.

Precautions

It is contraindicated in patients allergic to nifedipine.

Special Population Medication

Precautions for children: Safety and efficacy are not yet clear. Precautions for pregnancy and lactation: Pregnant women are prohibited from using this drug. Precautions for the elderly: After taking this drug, its half-life is prolonged, and Cmax and AUC are increased. Be careful to start taking it from the lowest dose to reduce the incidence of adverse reactions.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

seal.

Packaging Specification

10mg

Validity Period

24 months

Manufacturer

Taiji Group Chongqing Peiling Pharmaceutical Co., Ltd.

  • Founded in:

    1995-03-30
  • Address:

    No. 1 Taiji Avenue, Fuling District, Chongqing
  • Tax NO.:

    91500102208500610F
  • Registered Funds:

    900 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.